Full Text
Full Text PDF
Abstract
Abstract
Chordomas are rare malignant bone tumours with a predilection for the axial skeleton, especially the sacrum and skull base. Median survival in patients with metastatic disease is usually dismal. Treatment is challenging due to the propensity for local recurrence, metastatic disease as well as lack of clear consensus regarding the optimal management. Our case report highlights two cases of sacral chordoma with locally recurrent and widespread metastatic disease, stable on molecular targeted therapy.
Similar Articles
Article Info
Published In
Journal
The Eurasian Journal of Medicine
Volume / Issue
Volume 47 · Issue 2 · January 2015
Pages
151-154
History
Published Online
September 3, 2019
Copyright
Copyright (c) 2015 The Eurasian Journal of Medicine
Affiliations
Saurabh Rohatgi
Brigham and Women's Hospital/Dana Farber Cancer institute/ Harvard Medical School - Radiology Boston
Nikhil H Ramaiya
Brigham and Women's Hospital/Dana Farber Cancer institute/ Harvard Medical School - Radiology Boston
Jyothi P. Jagannathan
Brigham and Women's Hospital/Dana Farber Cancer institute/ Harvard Medical School - Radiology Boston
Stephanie A. Howard
Brigham and Women's Hospital/Dana Farber Cancer institute/ Harvard Medical School - Radiology Boston
Atul B. Shinagare
Brigham and Women's Hospital/Dana Farber Cancer institute/ Harvard Medical School - Radiology Boston
Katherine M. Krajewski
Brigham and Women's Hospital/Dana Farber Cancer institute/ Harvard Medical School - Radiology Boston
Cite this Article
Rohatgi, S., Ramaiya, N. H., Jagannathan, J. P., Howard, S. A., Shinagare, A. B., & Krajewski, K. M. (2019). Metastatic Chordoma: Report of the Two Cases and Review of the Literature. The Eurasian Journal of Medicine, 47(2), 151–154. https://doi.org/10.5152/eurasianjmed.2015.52
Outlines